Andrew Artenstein to HIV Antibodies
This is a "connection" page, showing publications Andrew Artenstein has written about HIV Antibodies.
Connection Strength
0.184
-
Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KF, Veit SC, Rogers AF, Garner RP, Byron JW, Burnett PR, Birx DL. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis. 1997 Feb; 175(2):265-71.
Score: 0.129
-
Williams SB, Flanigan TP, Artenstein AW, VanCott TC, Smith D, Mayer K, Koup RA. CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection. J Infect Dis. 1999 May; 179(5):1310-2.
Score: 0.038
-
Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis. 1999 Jan; 179(1):59-67.
Score: 0.009
-
Gaywee J, Artenstein AW, VanCott TC, Trichavaroj R, Sukchamnong A, Amlee P, de Souza M, McCutchan FE, Carr JK, Markowitz LE, Michael R, Nittayaphan S. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 01; 13(4):392-6.
Score: 0.008